Polyethylene glycol versus dual sugar assay for gastrointestinal permeability analysis: Is it time to choose?

Clinical and Experimental Gastroenterology

Volumn 5, Issue 1, 2012, Pages 139-150

  van Wijck, Kim ^a,b   Bessems, Babs A F M ^b   van Eijk, Hans M H ^b   Buurman, Wim A ^b   Dejong, Cornelis H C ^a,b   Lenaerts, Kaatje ^a,b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dual sugar; Gastrointestinal permeability; Polyethylene glycol

Indexed keywords

CALGRANULIN; FATTY ACID BINDING PROTEIN; INDOMETACIN; LACTULOSE; MACROGOL; MACROGOL 1500; MACROGOL 3350; MACROGOL 400; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; ASSAY; CELL LOSS; CONTROLLED STUDY; DUAL SUGAR ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; INTESTINE CELL; INTESTINE MUCOSA PERMEABILITY; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; POLYETHYLENE GLYCOL PERMEABILITY ASSAY; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINARY EXCRETION;

EID: 84930477870     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S31799     Document Type: Article

References (38)

1. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology. 1995;108(5):1566-1581.
2. Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin. 2005;21(2):177-196.
3. Chang M, Kistler EB, Schmid-Schonbein GW. Disruption of the mucosal barrier during gut ischemia allows entry of digestive enzymes into the intestinal wall. Shock. 2012;37(3):297-305.
4. Heyman M, Abed J, Lebreton C, Cerf-Bensussan N. Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Gut. September 2, 2011. [Epub ahead of print.]
5. Katz KD, Hollander D, Vadheim CM, et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology. 1989;97(4):927-931.
6. Zuckerman MJ, Watts MT, Bhatt BD, Ho H. Intestinal permeability to [51Cr]EDTA in infectious diarrhea. Dig Dis Sci. 1993;38(9): 1651-1657.
7. Besselink MG, van Santvoort HC, Renooij W, et al. Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis. Ann Surg. 2009;250(5):712-719.
8. Davies NM. Review article: non-steroidal anti-inflammatory drug-induced gastrointestinal permeability. Aliment Pharmacol Ther. 1998;12(4):303-320.
9. Zeng W. Communicating radiation exposure: a simple approach. J Nucl Med Technol. 2001;29(3):156-158.
10. van Wijck K, van Eijk HM, Buurman WA, Dejong CH, Lenaerts K. Novel analytical approach to a multi-sugar whole gut permeability assay. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(26): 2794-2801.
11. Fihn BM, Sjoqvist A, Jodal M. Permeability of the rat small intestinal epithelium along the villus-crypt axis: effects of glucose transport. Gastroenterology. 2000;119(4):1029-1036.
12. Van Itallie CM, Holmes J, Bridges A, et al. The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J Cell Sci. 2008;121(Pt 3):298-305.
13. Meddings JB, Gibbons I. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology. 1998;114(1): 83-92.
14. Meddings JB, Sutherland LR, Byles NI, Wallace JL. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology. 1993;104(6):1619-1626.
15. van Wijck K, Lenaerts K, van Loon LJ, Peters WH, Buurman WA, Dejong CH. Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men. PLoS One. 2011;6(7):e22366.
16. Cox MA, Lewis KO, Cooper BT. Measurement of small intestinal permeability markers, lactulose, and mannitol in serum: results in celiac disease. Dig Dis Sci. 1999;44(2):402-406.
17. European Food Safety Authority. Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food on a request from the commission related to an application on the use of polyethylene glycol (PEG) as a film coating agent for use in food supplement products. Available at: http://www.efsa.europa.eu/en/scdocs/doc/afc_op_ej414_polyethylene_glycol_sum_en%20,0.pdf. Accessed June 5, 2012.
18. Castle L, Cloke HR, Crews C, Gilbert J. The migration of propylene glycol, mono-, di-, and triethylene glycols from regenerated cellulose film into food. Z Lebensm Unters Forsch. 1988;187(5):463-467. German.
19. Chadwick VS, Phillips SF, Hofmann AF. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 400. Gastroenterology. 1977;73(2):241-246.
20. Chadwick VS, Phillips SF, Hofmann AF. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology. 1977;73(2):247-251.
21. Bjarnason I, Williams P, Smethurst P, Peters TJ, Levi AJ. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut. 1986;27(11):1292-1297.
22. Bjarnason I, Takeuchi K. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. J Gastroenterol. 2009;44 Suppl 19:23-29.
23. Parlesak A, Bode JC, Bode C. Parallel determination of gut permeability in man with M(r) 400, M(r) 1500, M(r) 4000 and M(r) 10,000 polyethylene glycol. Eur J Clin Chem Clin Biochem. 1994;32(11):813-820.
24. Kerckhoffs AP, Akkermans LM, de Smet MB, et al. Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs. Dig Dis Sci. 2010;55(3):716-723.
25. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta. 2005;352(1-2):15-35.
26. van Nieuwenhoven MA, de Swart EA, van Eijk HM, Deutz NE, Brouns F, Brummer RJ. Effects of pre-and post-absorptive factors on the lactulose/rhamnose gut permeability test. Clin Sci (Lond). 2000;98(3):349-353.
27. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343(8900):769-772.
28. Loret S, Nollevaux G, Remacle R, et al. Analysis of PEG 400 and 4000in urine for gut permeability assessment using solid phase extraction and gel permeation chromatography with refractometric detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;805(2):195-202.
29. Lee S, Son SC, Han MJ, et al. Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites. World J Gastroenterol. 2008;14(24):3884-3890.
30. Menzies IS, Zuckerman MJ, Nukajam WS, et al. Geography of intestinal permeability and absorption. Gut. 1999;44(4):483-489.
31. Ma TY, Hollander D, Krugliak P, Katz K. PEG 400, a hydrophilic molecular probe for measuring intestinal permeability. Gastroenterology. 1990;98(1):39-46.
32. Bijlsma PB, Fihn BM, Sjoqvist A, Groot JA, Taminiau JA, Jodal M. Water absorption enhances the uptake of mannitol and decreases Cr-EDTA/mannitol permeability ratios in cat small intestine in situ. Scand J Gastroenterol. 2002;37(7):799-806.
33. Bours MJ, Bos HJ, Meddings JB, Brummer RJ, van den Brandt PA, Dagnelie PC. Effects of oral adenosine 5′-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study. BMC Gastroenterol. 2007;7:23.
34. Troost FJ, Saris WH, Brummer RJ. Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers. Eur J Clin Nutr. 2003;57(12):1579-1585.
35. Playford RJ, MacDonald CE, Calnan DP, et al. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Clin Sci (Lond). 2001;100(6):627-633.
36. Marchbank T, Limdi JK, Mahmood A, Elia G, Playford RJ. Clinical trial: protective effect of a commercial fish protein hydrolysate against indomethacin (NSAID)-induced small intestinal injury. Aliment Pharmacol Ther. 2008;28(6):799-804.
37. Mahmood A, Fitzgerald AJ, Marchbank T, et al. Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes. Gut. 2007;56(2):168-175.
38. Bjarnason I, Maxton D, Reynolds AP, Catt S, Peters TJ, Menzies IS. Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease. Scand J Gastroenterol. 1994;29(7):630-639.